Home > Insider Trading > Pdl Biopharma Inc.

Pdl Biopharma Inc. (PDLI)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 37

Theravance Inc (THRX) Looks to Reward Shareholders by Splitting Into Two Distinct Companies

As part of the split, the pharmaceutical company looks poised to turn its current drug-marketing joint venture with London-based GlaxoSmithKline plc (ADR) (NYSE:GSK) into an independent firm.

Keep Reading →

May 15th, 2013 - News

Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up

Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into animal health products...

Keep Reading →

April 26th, 2013 - News

Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?

MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds' portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge fund interest of late.

Keep Reading →

April 13th, 2013 - News

PDL BioPharma Inc. (NASDAQ:PDLI): Insiders Are Dumping, Should You? - Santarus, Inc. (NASDAQ:SNTS), VIVUS, Inc. (NASDAQ:VVUS)

In the 21st century investor’s toolkit, there are a multitude of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.

Keep Reading →

April 2nd, 2013 - News

Does PDL BioPharma Inc. (PDLI)'s Dividend Have Room to Soar?

With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.

Keep Reading →

March 14th, 2013 - News

The 25 Highest-Yielding Dividend Stocks in March: Seadrill Ltd (SDRL), Boise Inc. (BZ), Windstream Corporation (WIN)

The highest dividend yields can be very tantalizing.

Keep Reading →

March 8th, 2013 - News

The Fight Over This Biotech's Cash: Elan Corporation, plc (ADR) (ELN)

Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech stands to get from Biogen Idec Inc.

Keep Reading →

February 25th, 2013 - News